(Q35659879)

English

Phase II study of methotrexate, vincristine, pegylated-asparaginase, and dexamethasone (MOpAD) in patients with relapsed/refractory acute lymphoblastic leukemia

scientific article published on 19 November 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 August 2017

Phase II study of methotrexate, vincristine, pegylated-asparaginase, and dexamethasone (MOpAD) in patients with relapsed/refractory acute lymphoblastic leukemia (English)

1 reference

Europe PubMed Central

9 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

Hagop Kantarjian

2

object named as

Hagop M Kantarjian

1 reference

Europe PubMed Central

9 August 2017

5

object named as

Zeev Estrov

1 reference

Europe PubMed Central

9 August 2017

Jorge Eduardo Cortes

15

object named as

Jorge Cortes

1 reference

Europe PubMed Central

9 August 2017

4

object named as

Susan O'Brien

1 reference

Europe PubMed Central

9 August 2017

6

object named as

Farhad Ravandi

1 reference

Europe PubMed Central

9 August 2017

7

object named as

Elias Jabbour

1 reference

Europe PubMed Central

9 August 2017

Gautam Borthakur

16

object named as

Gautam Borthakur

1 reference

Europe PubMed Central

9 August 2017

12

object named as

Sherry Pierce

1 reference

Europe PubMed Central

9 August 2017

Guillermo Garcia-Manero

14

object named as

Guillermo Garcia-Manero

1 reference

Europe PubMed Central

9 August 2017

Naveen Pemmaraju

8

object named as

Naveen Pemmaraju

1 reference

Europe PubMed Central

9 August 2017

1

object named as

Tapan M Kadia

1 reference

Europe PubMed Central

9 August 2017

9

object named as

Naval Daver

1 reference

Europe PubMed Central

9 August 2017

13

object named as

Mark Brandt

1 reference

Europe PubMed Central

9 August 2017

11

object named as

Preetesh Jain

1 reference

Europe PubMed Central

9 August 2017

author name string

Deborah A Thomas

3

1 reference

Europe PubMed Central

9 August 2017

Xuemei Wang

10

1 reference

Europe PubMed Central

9 August 2017

publication date

19 November 2014

1 reference

Europe PubMed Central

9 August 2017

American Journal of Hematology

1 reference

Europe PubMed Central

9 August 2017

90

1 reference

Europe PubMed Central

9 August 2017

120-124

1 reference

Europe PubMed Central

9 August 2017

2

1 reference

Europe PubMed Central

9 August 2017

Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4447180

12 July 2018

Asparaginase revisited

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4447180

12 July 2018

First report of phase 2 study of dasatinib with hyper-CVAD for the frontline treatment of patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4447180

12 July 2018

Peg-asparaginase for acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4447180

12 July 2018

Adult acute lymphoblastic leukemia: concepts and strategies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4447180

12 July 2018

Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 9511

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4447180

12 July 2018

Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4447180

12 July 2018

Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4447180

12 July 2018

Schedule-dependent therapeutic synergism for L-asparaginase and methotrexate in leukemic (L5178Y) mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4447180

12 July 2018

Lower incidence of meningeal leukemia when prednisone is replaced by dexamethasone in the treatment of acute lymphocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4447180

12 July 2018

Methotrexate and asparaginase combination chemotherapy in refractory acute lymphoblastic leukemia of childhood

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4447180

12 July 2018

Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23886

21 January 2018

Outcome of adults with acute lymphocytic leukemia after second salvage therapy

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23886

21 January 2018

Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23886

21 January 2018

New statistical strategy for monitoring safety and efficacy in single-arm clinical trials.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23886

21 January 2018

Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23886

21 January 2018

Comparative cytotoxicity of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23886

21 January 2018

Comparison of the antileukemic activity in vitro of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23886

21 January 2018

Long-term follow-up of treatment and potential cure of adult acute lymphocytic leukemia with MOAD: a non-anthracycline containing regimen.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4447180

25 September 2018

Asparaginase-methotrexate in combination chemotherapy: schedule-dependent differential effects on normal versus neoplastic cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4447180

25 September 2018

L-asparaginase-induced modulation of methotrexate polyglutamylation in murine leukemia L5178Y.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4447180

25 September 2018

Acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23886

21 January 2018

Hypersensitivity reactions to L-asparaginase do not impact on the remission duration of adults with acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25368968

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination therapy with methotrexate, vincristine, polyethylene-glycol conjugated-asparaginase, and prednisone in the treatment of patients with refractory or recurrent acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25368968

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary refractory and relapsed adult acute lymphoblastic leukemia: characteristics, treatment results, and prognosis with salvage therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25368968

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/25368968

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of methotrexate cytotoxicity by asparaginase inhibition of methotrexate polyglutamate formation

1 reference

https://pubmed.ncbi.nlm.nih.gov/25368968

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/AJH.23886

1 reference

Europe PubMed Central

9 August 2017

1 reference

Europe PubMed Central

9 August 2017

1 reference

Europe PubMed Central

9 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35659879&oldid=2108629292"